System, Test, Automated, Antimicrobial Susceptibility, Short Incubation
System, Test, Automated, Antimicrobial Susceptibility, Short Incubation is an automated microbiology system that rapidly determines the susceptibility or resistance of bacterial isolates to a panel of antimicrobial agents using abbreviated incubation periods, providing clinically actionable results more quickly than conventional methods to guide antibiotic therapy selection. It is classified as FDA Class 2, indicating moderate risk, and requires 510(k) premarket clearance. The product code is LON, regulated under 21 CFR 866.1645, within the Microbiology medical specialty. No special flags apply to this device.
Research product code LON in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- LON
- Device Class
- FDA class 2
- Regulation Number
- 866.1645
- Medical Specialty
- Microbiology
- Review Panel
- MI
- Submission Type
- 1
Device Characteristics
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 289 510(k) clearances via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K260282 | VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance | Apr 15, 2026 | Substantially Equivalent | bioMerieux, Inc. |
| K260281 | VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) | Mar 26, 2026 | Substantially Equivalent | BIOMERIEUX |
| K251579 | VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) | Aug 21, 2025 | Substantially Equivalent | bioMerieux, Inc. |
| K251713 | BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL) | Aug 08, 2025 | Substantially Equivalent | Becton, Dickinson and Company |
| K250447 | BD Phoenix Automated Microbiology System - GN Imipenem-relebactam (0.0625/4 - 16/4 µg/mL) | May 19, 2025 | Substantially Equivalent | Becton, Dickinson and Company |
| K234012 | VITEK COMPACT PRO | Mar 14, 2025 | Substantially Equivalent | bioMerieux, Inc. |
| K250344 | BD Phoenix Automated Microbiology System | Mar 06, 2025 | Substantially Equivalent | Becton, Dickinson and Company |
| K233986 | BD Phoenix Automated Microbiology System - GN Ciprofloxacin (0.01564 µg/mL) | Mar 15, 2024 | Substantially Equivalent | Becton, Dickinson and Company |
| K234000 | VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL) | Mar 11, 2024 | Substantially Equivalent | bioMerieux, Inc. |
| K232756 | Colibrí | Dec 27, 2023 | Substantially Equivalent | Copan Wasp Srl |
| K232201 | VITEK 2 AST-Streptococcus Penicillin (<=0.06 - =>8 µg/mL), VITEK 2 Streptococcus Penicillin (<=0.06 - >=8 µg/mL), VITEK 2 Streptococcus Penicillin | Oct 23, 2023 | Substantially Equivalent | bioMerieux, Inc. |
| K230864 | VITEK 2 AST-Gram Positive Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin (<=0.12 - >=8 µg/mL), VITEK 2 AST-GP Daptomycin | Jul 05, 2023 | Substantially Equivalent | bioMerieux, Inc. |
| K222378 | VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL) | Jun 26, 2023 | Substantially Equivalent | bioMerieux, Inc. |
| K211748 | Selux AST System; Model AST Gen 1.0 | Apr 19, 2023 | Substantially Equivalent | Selux Diagnostics, Inc. |
| K222430 | VITEK 2 AST-Gram Negative Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin (<=4 - >=256 µg/mL), VITEK 2 AST-GN Fosfomycin | Mar 09, 2023 | Substantially Equivalent | Biomerieux Sa, Inc. |
| K223478 | VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin | Feb 16, 2023 | Substantially Equivalent | bioMerieux, Inc. |
| K222073 | VITEK 2 AST-Gram Negative Cefazolin (<=1 - >=32 ug/mL) | Feb 09, 2023 | Substantially Equivalent | bioMerieux, Inc. |
| K223481 | VITEK® 2 Streptococcus Tetracycline (<=0.25 - >=16 µg/mL) | Feb 03, 2023 | Substantially Equivalent | bioMerieux, Inc. |
| K220803 | VITEK 2 AST-Gram Positive Moxifloxacin (=0.25 - =8 µg/ml), VITEK 2 AST-GP Moxifloxacin (=0.25 - =8 µg/mL), VITEK 2 AST-GP Moxifloxacin | Jan 27, 2023 | Substantially Equivalent | bioMerieux, Inc. |
| K211759 | Selux AST System; Model AST Gen 1.0 | Jan 18, 2023 | Substantially Equivalent | Selux Diagnostics, Inc. |
| K220805 | VITEK 2 AST-Gram Positive Cefoxitin Screen | Oct 13, 2022 | Substantially Equivalent | bioMerieux, Inc. |
| K220546 | Colibrí System | Oct 05, 2022 | Substantially Equivalent | Copan Wasp Srl |
| K212243 | VITEK 2 AST- Gram Positive Telavancin (<=0.015 - >=1 µg/mL) | Aug 08, 2022 | Substantially Equivalent | bioMerieux, Inc. |
| K213899 | VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin | Jul 12, 2022 | Substantially Equivalent | bioMerieux, Inc. |
| K213931 | VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 µg/mL) | Jun 03, 2022 | Substantially Equivalent | bioMerieux, Inc. |
| K214023 | VITEK 2 AST-Gram Negative Ciprofloxacin (?0.06 - ?4 µg/mL) | Apr 14, 2022 | Substantially Equivalent | bioMerieux, Inc. |
| K213241 | VITEK 2 AST-Yeast Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole (<=0.5->=64 µg/mL), VITEK 2 AST-YS Fluconazole | Feb 25, 2022 | Substantially Equivalent | bioMerieux, Inc. |
| K212849 | VITEK 2 AST-Gram Positive Linezolid (<=0.5 >=8 µg/mL) | Feb 04, 2022 | Substantially Equivalent | Biomérieux, Inc. |
| K210287 | VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL) | Oct 28, 2021 | Substantially Equivalent | bioMerieux, Inc. |
| K202396 | VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL) | Sep 14, 2021 | Substantially Equivalent | bioMerieux, Inc. |
| K211630 | VITEK 2 AST-Gram Negative Piperacillin / Tazobactam (<=4 - =>128 µg/mL) | Aug 30, 2021 | Substantially Equivalent | bioMerieux, Inc. |
| K201675 | VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL) | Jul 09, 2021 | Substantially Equivalent | bioMerieux, Inc. |
| K211136 | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<0.25/4 - >16/4 ug/ML) | Jun 14, 2021 | Substantially Equivalent | bioMerieux, Inc. |
| K193299 | VITEK 2 AST-Gram Negative Ceftazidime (=<0.5 - =>32 µg/mL) | Sep 28, 2020 | Substantially Equivalent | bioMerieux, Inc. |
| K201405 | LabPro Data Management System | Aug 30, 2020 | Substantially Equivalent | Beckman Coulter, Inc. |
| K200590 | VITEK 2 AST-Gram Positive Delafloxacin (<=0.015 - >=1 µg/mL) | Apr 28, 2020 | Substantially Equivalent | bioMerieux, Inc. |
| K193572 | VITEK 2 AST-Gram Negative Imipenem/Relebactam (<=0.25/4 - >=16/4 µg/mL) | Mar 13, 2020 | Substantially Equivalent | bioMerieux, Inc. |
| K193567 | VITEK 2 AST- Gram Negative Polymyxin B (<=0.25 >=16 ug/mL) | Feb 14, 2020 | Substantially Equivalent | bioMerieux, Inc. |
| K192110 | Vitek Densichek | Oct 31, 2019 | Substantially Equivalent | bioMerieux, Inc. |
| K191766 | VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL) | Aug 05, 2019 | Substantially Equivalent | bioMerieux, Inc. |
| K190905 | BD Phoenix Automated Microbiology System GN Ceftaroline (0.0156-4 µg/mL) | Jul 01, 2019 | Substantially Equivalent | Becton, Dickinson and Company |
| K190616 | VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL) | Jun 06, 2019 | Substantially Equivalent | bioMerieux, Inc. |
| K183524 | VITEK2 AST-Gram Negative Delafloxacin (<=0.06->=4 ug/mL) | Mar 12, 2019 | Substantially Equivalent | bioMerieux, Inc. |
| K183551 | VITEK 2 AST-Gram Negative Minocycline (<= 0.5 - >= 32 ug/mL) | Mar 07, 2019 | Substantially Equivalent | bioMerieux, Inc. |
| K183360 | VITEK 2 AST-Gram Negative Meropenem/Vaborbactam (<=0.5/8 >=64/8 µg/mL) | Feb 26, 2019 | Substantially Equivalent | bioMerieux, Inc. |
| K183415 | VITEK 2 AST-Gram Negative Imipenem (</=0.25->= 16 ug/mL) | Feb 20, 2019 | Substantially Equivalent | bioMerieux, Inc. |
| K181766 | VITEK 2 AST-Gram Positive Inducible Clindamycin Resistance | Dec 10, 2018 | Substantially Equivalent | bioMerieux, Inc. |
| K181665 | BD Phoenix Automated Microbiology System - BD Phoenix CPO detect - GN | Sep 21, 2018 | Substantially Equivalent | Becton, Dickinson and Company |
| K173523 | BD Phoenix Automated Microbiology System - GN Meropenem-vaborbactam (0.125/8-32/8 ug/mL) | Feb 09, 2018 | Substantially Equivalent | Becton, Dickinson and Company |
| K173252 | BD Phoenix Automated Microbiology System - GN Ceftolozane/tazobactam (0.25/4-32/4 ug/mL) | Jan 05, 2018 | Substantially Equivalent | Becton, Dickinson and Company |
| K172944 | VITEK 2 AST-GN Ceftazidime/Avibactam <=0.12 >=16 µg/mL | Dec 19, 2017 | Substantially Equivalent | bioMerieux, Inc. |
| K172731 | VITEK 2 AST-GN Amikacin (<=1 ->=64 ug/mL) | Dec 08, 2017 | Substantially Equivalent | bioMerieux, Inc. |
| K162737 | VITEK 2 AST-GN Ciprofloxacin (<=0.06->=4µg/mL) | Jun 21, 2017 | Substantially Equivalent | bioMerieux, Inc. |
| K163637 | BD Phoenix Automated Microbiology System - GN Ceftazidime/avibactam (0.25/4- 32/4ug/mL) | Mar 21, 2017 | Substantially Equivalent | Becton Dickinson & Company |
| K163563 | VITEK 2 AST-GN Gentamicin (<=1 >=16 µg/mL) | Mar 13, 2017 | Substantially Equivalent | bioMerieux, Inc. |
| K161437 | VITEK 2 AST Gram Negative Cefotaxime (<=0.25 - >=64 ug/mL) | Feb 16, 2017 | Substantially Equivalent | bioMerieux, Inc. |
| K161510 | VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) | Feb 13, 2017 | Substantially Equivalent | bioMerieux, Inc. |
| K163083 | VITEK 2 AST-GN Tobramycin (</=1->/= 16 ug/mL); VITEK 2 AST-Gram Negative Tobramycin (</=1->/=16 ug/mL) | Feb 01, 2017 | Substantially Equivalent | bioMerieux, Inc. |
| K163006 | VITEK 2 AST-GN Tigecycline (<0.5->8 ug/mL) | Jan 24, 2017 | Substantially Equivalent | bioMerieux, Inc. |
| K161217 | VITEK 2 Gram Negative Ceftriaxone (<=0.25->=64 ug/mL) | Jan 12, 2017 | Substantially Equivalent | bioMerieux, Inc. |
| K161227 | VITEK 2 AST-GN Cefepime (<=0.12->=32 ug/mL) | Jul 20, 2016 | Substantially Equivalent | bioMerieux, Inc. |
| K152075 | VITEK 2 AST-Gram Negative Ertapenem (<=0.12 - >=8 ug/mL) | Apr 15, 2016 | Substantially Equivalent | bioMerieux, Inc. |
| K151320 | BD Phoenix Automated Microbiology System-Ertapenem 0.0625-8 mcg/ml | Jan 15, 2016 | Substantially Equivalent | Becton, Dickinson and Company |
| K142170 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTESM - TIGECYCLINE (0.313-4UG/ML) GP | Oct 28, 2014 | Substantially Equivalent | Becton, Dickinson and Company |
| K141149 | VITEK 2 AST GP CEFTAROLINE | Jun 20, 2014 | Substantially Equivalent | bioMerieux, Inc. |
| K140468 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFTAROLINE (0.625-4 UG/ML) | Jun 02, 2014 | Substantially Equivalent | Becton, Dickinson and Company |
| K132909 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM TIGECYCLINE (0.25-16 UG/ML) | Feb 14, 2014 | Substantially Equivalent | Becton, Dickinson and Company |
| K132674 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM- MEROPENEM (0.125-32 UG/ML) | Dec 27, 2013 | Substantially Equivalent | Becton, Dickinson and Company |
| K132507 | VITEK 2 AST ST MEROPENEM | Nov 15, 2013 | Substantially Equivalent | bioMerieux, Inc. |
| K131779 | VITEK 2 AST-ST TIGECYCLINE | Oct 10, 2013 | Substantially Equivalent | bioMerieux, Inc. |
| K132573 | VITEK 2 AST ST MOXIFLOXACIN, VITEK 2 AST STREPTOCOCCUS MOXIFLOXACIN | Sep 13, 2013 | Substantially Equivalent | bioMerieux, Inc. |
| K131331 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - VANCOMYCIN (0.5-32 UG/ML) | Jul 10, 2013 | Substantially Equivalent | Becton, Dickinson & CO |
| K123404 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM- IMIPENEM (0.0625-32 UG/ML) | Jun 27, 2013 | Substantially Equivalent | Becton, Dickinson & CO |
| K123266 | BD PHOENIX AUTOMATED MICROIOLOGY SYSTEM- ERTAPENEM 0.0625-8 UG/ML-GN | Jun 26, 2013 | Substantially Equivalent | Becton, Dickinson and Company |
| K121546 | VITEK 2 GRAM NEGATIVE DOXYCYCLINE | Nov 20, 2012 | Substantially Equivalent | bioMerieux, Inc. |
| K121100 | VITEK 2 AST STREPTOCOCUS VANCOMYCIN | Nov 19, 2012 | Substantially Equivalent | bioMerieux, Inc. |
| K122547 | GRAM POSTITVE CLINDAMYCIN | Oct 15, 2012 | Substantially Equivalent | bioMerieux, Inc. |
| K122359 | VITEK 2 STRPTOCOCCUS CEFTRIAXONE | Aug 28, 2012 | Substantially Equivalent | bioMerieux, Inc. |
| K121863 | VITEK 2 AST-ST CEFOTAXIME | Aug 16, 2012 | Substantially Equivalent | bioMerieux, Inc. |
| K113783 | VITEK 2 AST- GRAM POSTIVE PENICILLIN FOR STREPTOCOCCUS PNEUMONIAE | Aug 07, 2012 | Substantially Equivalent | bioMerieux, Inc. |
| K113200 | VITEK 2 AST-GN PIPERACILLIN/TAZOBACTAM | Jun 29, 2012 | Substantially Equivalent | bioMerieux, Inc. |
| K111893 | VITEK(R) 2 STREPTOCOCCUS TETRACYCLINE | Feb 28, 2012 | Substantially Equivalent | bioMerieux, Inc. |
| K111976 | VITEK 2 STREPTOCOCCUS ERYTHROMYCIN | Feb 17, 2012 | Substantially Equivalent | bioMerieux, Inc. |
| K113305 | VITEK 2 STREPTOCOCCUS TRIMETHOPRIM/SULFAMETHOXAZOLE | Feb 10, 2012 | Substantially Equivalent | bioMerieux, Inc. |
| K110106 | VITEK 2 GRAM NEGATIVE TRIMETHOPRIM/SULFAMETHOAZOLE | Nov 30, 2011 | Substantially Equivalent | bioMerieux, Inc. |
| K112000 | VITEK 2 STREPTOCOCCUS PENICILLIN | Oct 26, 2011 | Substantially Equivalent | bioMerieux, Inc. |
| K111909 | VITEK 2 STREPTOCOCCUS INDUCIBLE CLINDAMYCIN RESISTANCE | Oct 18, 2011 | Substantially Equivalent | bioMerieux, Inc. |
| K103752 | VITEK 2 SYSTEMS (PC) 5.02 SOFTWARE | Oct 14, 2011 | Substantially Equivalent | bioMerieux, Inc. |
| K112228 | VITEK 2 STREPTOCOCCUS LEVOFLOXACIN | Oct 03, 2011 | Substantially Equivalent | bioMerieux, Inc. |
| K112129 | VITEK(R) 2 STREPTOCOCCUS CLINDAMYCIN | Sep 27, 2011 | Substantially Equivalent | bioMerieux, Inc. |
| K112075 | VITEK 2 STRPTOCOCCUS AMPICILLIN | Sep 15, 2011 | Substantially Equivalent | bioMerieux, Inc. |
| K111599 | VITEK 2 AST-ST LINEZOLID | Aug 12, 2011 | Substantially Equivalent | bioMerieux, Inc. |
| K093076 | VITEK 2 GRAM POSITIVE DOXCYCLINE | Oct 21, 2010 | Substantially Equivalent | bioMerieux, Inc. |
| K093224 | DENSICHECK PLUS | Nov 09, 2009 | Substantially Equivalent | bioMerieux, Inc. |
| K092919 | MICROSCAN SYNERGIES PLUS MIC/COMBO PANELS, MODEL B1025 | Oct 23, 2009 | Substantially Equivalent | Siemens Healthcare Diagnostics |
| K083536 | DENSICHEK PLUS | Sep 11, 2009 | Substantially Equivalent | bioMerieux, Inc. |
| K091899 | VITEK 2 GRAM NEGATIVE MEROPENEM | Aug 14, 2009 | Substantially Equivalent | bioMerieux, Inc. |
| K091126 | VITEK 2 GRAM POSITIVE DAPTOMYCIN | Jun 18, 2009 | Substantially Equivalent | bioMerieux, Inc. |
| K082346 | VITEK 2 GRAM NEGATIVE DORIPENEM | Mar 16, 2009 | Substantially Equivalent | bioMerieux, Inc. |
| K083383 | VITEK 2 GRAM POSITIVE ERYTHROMYCIN FOR STREPTOCOCCUS PNEUMONIAE | Feb 18, 2009 | Substantially Equivalent | bioMerieux, Inc. |
| K082852 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-NITROFURANTOIN (GP) 4-128 UG/ML | Jan 29, 2009 | Substantially Equivalent | Becton, Dickinson & CO |
| K082913 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-DOXYCYCLINE (GP) 0.25-16 UG/ML | Dec 05, 2008 | Substantially Equivalent | Becton, Dickinson & CO |
| K082538 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-PHOENIX INDUCIBLE MACROLIDE RESISTANCE TEST | Nov 20, 2008 | Substantially Equivalent | Becton, Dickinson & CO |
| K080201 | VITEK 2 GRAM POSITIVE INDUCIBLE CLINDAMYCIN RESISTANCE | Apr 30, 2008 | Substantially Equivalent | bioMerieux, Inc. |
| K073589 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-DAPTOMYCIN (0.0313-16 UG/ML) STEPTOCOCCUS ID/AST OR AST ONLY PHOENIX PANELS | Mar 05, 2008 | Substantially Equivalent | Becton, Dickinson & CO |
| K080107 | VITEK 2 GRAM NEGATIVE PIPERACILLIN/TAZOBACTAM | Feb 28, 2008 | Substantially Equivalent | bioMerieux, Inc. |
| K073406 | VITEK 2 GRAM NEGATIVE TRIMETHOPRIM/SULFAMETHOXAZOLE | Jan 23, 2008 | Substantially Equivalent | bioMerieux, Inc. |
| K073433 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-PIPERACILLIN (GN) -128 UG/ML | Jan 14, 2008 | Substantially Equivalent | Becton, Dickinson & CO |
| K073083 | VITEK 2 GRAM NEGATIVE PIPERACILLIN | Dec 10, 2007 | Substantially Equivalent | bioMerieux, Inc. |
| K072695 | VITEK 2 GRAM POSITIVE TIGECYCLINE | Nov 16, 2007 | Substantially Equivalent | bioMerieux, Inc. |
| K072668 | VITEK 2 GRAM POSITIVE VANCOMYCIN | Oct 15, 2007 | Substantially Equivalent | bioMerieux, Inc. |
| K070809 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-MINOCYCLINE (GP) 1-32 UG/ML | Sep 24, 2007 | Substantially Equivalent | Becton, Dickinson & CO |
| K072038 | VITEK 2 GRAM NEGATIVE LEVOFLOXACIN | Sep 12, 2007 | Substantially Equivalent | bioMerieux, Inc. |
| K071623 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM, AMPICILLIN-SULBACTAM (GN) 1/0.5-32/16 UG/ML | Aug 20, 2007 | Substantially Equivalent | Becton, Dickinson & CO |
| K071317 | MICROSCAN SYNERGIES PLUS GRAM POSITIVE MIC/COMBO PANELS NEW ANTIMICROBIAL-GENTAMICIN SYNERGY SCREEN | Aug 20, 2007 | Substantially Equivalent | Dade Behring, Inc. |
| K070346 | DADE BEHRING LABPRO ALERT SOFTWARE SYSTEM | Jul 18, 2007 | Substantially Equivalent | Dade Behring, Inc. |
| K071268 | MICROSCAN SYNERGIES PLUS GRAM POSITIVE MIC/COMBO PANELS WITH TETRACYCLINE | Jun 26, 2007 | Substantially Equivalent | Dade Behring, Inc. |
| K071076 | SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS | May 21, 2007 | Substantially Equivalent | Dade Behring, Inc. |
| K070860 | MICROSCAN SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS WITH CLINDAMYCIN | May 11, 2007 | Substantially Equivalent | Dade Behring, Inc. |
| K063486 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM MINOCYCLINE (1-32 UG/ML) GRAM NEGATIVE ID/AST OR AST ONLY | Mar 07, 2007 | Substantially Equivalent | Becton, Dickinson & CO |
| K063824 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - AZTREONAM (GN) 0.5-64UG/ML | Feb 14, 2007 | Substantially Equivalent | Becton, Dickinson & CO |
| K063811 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFAZOLIN (GN) 0.5-32UG/ML | Feb 09, 2007 | Substantially Equivalent | Becton, Dickinson & CO |
| K063564 | MICROSCAN SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS WITH CHLORAMPHENICOL (4-16 UG/ML) | Feb 08, 2007 | Substantially Equivalent | Dade Behring, Inc. |
| K063300 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFPODOXIME (GN) 0.125-8UG/ML | Jan 29, 2007 | Substantially Equivalent | Becton, Dickinson & CO |
| K063597 | VITEK 2 GRAM POSITIVE AMOXICILLIN FOR STREPTOCOCCUS PNEUMONIAE | Jan 19, 2007 | Substantially Equivalent | bioMerieux, Inc. |
| K063623 | VITEK 2 GRAM POSITIVE MEROPENEM FOR STREPTOCOCCUS PNEUMONIAE | Jan 11, 2007 | Substantially Equivalent | bioMerieux, Inc. |
| K063573 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFTAZIDIME (GN) 0.5-64 UG/ML | Jan 11, 2007 | Substantially Equivalent | Becton, Dickinson & CO |
| K063492 | VITEK 2 GRAM POSITIVE ERYTHROMYCIN FOR STREPTOCOCCUS PNEUMONIAE | Dec 21, 2006 | Substantially Equivalent | bioMerieux, Inc. |
| K063366 | MICROSCAN SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANEL WITH SYNERCID (0.12-2UG/ML 5DILUTION BREAKPOINT SEQUENCE | Dec 08, 2006 | Substantially Equivalent | Dade Behring, Inc. |
| K063365 | SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS WITH GENTAMICIN (0.06-32MG/ML LONG DILUTION SEQUENCE | Dec 08, 2006 | Substantially Equivalent | Dade Behring, Inc. |
| K063301 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFEPIME (GN) 0.5-64UG/ML | Dec 08, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K062945 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - ERTAPENEM (GN) 0.25-32 UG/ML | Nov 21, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K062938 | MICROSCAN SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS WITH NITROFURANTOIN (2 - 256 UG/ML | Nov 20, 2006 | Substantially Equivalent | Dade Behring, Inc. |
| K062944 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFTRIAXONE (GN) 0.5-64UG/ML | Nov 15, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K062687 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEN - TICARCILLIN-CLAVULANATE (GN) 1/2 - 128/2UG/ML | Oct 24, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K062705 | SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS WITH LINEZOLID | Oct 20, 2006 | Substantially Equivalent | Dade Behring, Inc. |
| K062680 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TICARCILLIN (GN) 1-128 UG/ML | Oct 05, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K062207 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFUROXIME (GN) 1-64 UG/ML | Sep 13, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K062206 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - MOXIFLOXACIN (STREP) 0.0625 - 8UG/ML | Sep 08, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K061869 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-PIPERACILLIN-TAZOBACTAM (GP) 1/4-128/4 UG/ML | Aug 18, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K061867 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFAZOLIN (GN) 0.5-32 UG/ML | Aug 10, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K061673 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-AMOXICILLIN-CLAVULANATE(GP) 0.25/0.12 -32/16 UG/ML | Jul 28, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K061327 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-AMOXICILLIN-CLAVULANATE (GN) 0.5/0.25-32/16 UG/ML, AMPICILLIN-SULBACTAM (GN) 0. | Jul 03, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K061347 | VITEK 2 GRAM POSITIVE VRSA SCREEN | Jun 20, 2006 | Substantially Equivalent | bioMerieux, Inc. |
| K061355 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - AMPICILLIN (GN) 0.5-32 UG/ML | Jun 07, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K060324 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM FOR USE WITH THE ANTIMICROBIAL AGENT GATIFLOXACIN 0.25-8 UG/ML - GRAM-NEGATIVE | May 25, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K060558 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM CEPHALOTHIN - GN 1 - 64 UG/ML | May 11, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K060447 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM -NITROFURANTOIN (GN) 8-512 UG/ML, TRIMETHOPRIM-SULFAMETHOXAZOLE (GN) | Apr 26, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K060257 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFOXITIN - 0.5-64 UG/ML | Apr 14, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K060444 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFEPIME (GN) , CEFTRIAXONE (GN), CEFOTAXIME (GN), 0.5-64 UG/ML | Apr 12, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K060217 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - MOXIFLOXACIN-0.125-8 AND CIPROFLOXACIN-0.25 - 4 UG/ML | Apr 12, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K060493 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - VANCOMYCIN-GP DETECTION OF VRSA. | Mar 29, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K060312 | MICROSCAN SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS WITH VANCOMYCIN (0.25-64 UG/ML) | Mar 23, 2006 | Substantially Equivalent | Dade Behring, Inc. |
| K060218 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - ERYTHROMYCIN-0.0625-8 UG/ML, AND QUINUPRISTIN/DALFOPRISTIN-0.25-4 UG/ML | Mar 17, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K060214 | BD PHOENIX AUTOMATED MIRCROBIOLOGY SYSTEM TETRACYCLINE-GN 0.5-16 UG/ML AND GP 0.5-16 UG/ML | Mar 09, 2006 | Substantially Equivalent | Becton, Dickinson & CO |
| K053504 | MICROSCAN SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS WITH ERYTHROMYCIN (0.12-16 UG/ML) | Feb 24, 2006 | Substantially Equivalent | Dade Behring, Inc. |
| K060088 | MICROSCAN SYNERGIES PLUS GRAM POSITIVE MIC/COMBO PANELS - AMPICILLIN | Feb 03, 2006 | Substantially Equivalent | Dade Behring, Inc. |
| K053241 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFOXITIN GP 1-32 G/ML | Dec 22, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K053097 | VITEK 2 GRAM POSITIVE CEFOXITIN SCREEN | Dec 14, 2005 | Substantially Equivalent | bioMerieux, Inc. |
| K053186 | VITEK 2 GRAM POSITIVE TELITHROMYCIN FOR STREPTOCOCCUS PNEUMONIAE | Dec 01, 2005 | Substantially Equivalent | bioMerieux, Inc. |
| K052656 | VITEK GRAM POSITIVE SUSCEPTIBILITY DAPTOMYCIN | Nov 07, 2005 | Substantially Equivalent | bioMerieux, Inc. |
| K052346 | SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS | Oct 26, 2005 | Substantially Equivalent | Dade Behring, Inc. |
| K052270 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFUROXIME (STREP) 0.125 - 4UG/ML | Oct 05, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K052269 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM -CIPROFLOXACIN GN | Oct 03, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K052250 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TOBRAMYCIN (GP) 0.5-16UG/ML | Sep 30, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K052311 | VITEK 2 GRAM NEGATIVE TIGECYCLINE | Sep 29, 2005 | Substantially Equivalent | bioMerieux, Inc. |
| K051849 | VITEK 2 GRAM POSITIVE ERTAPENEM FOR STREPTOCOCCUS PNEUMONIAE | Aug 16, 2005 | Substantially Equivalent | bioMerieux, Inc. |
| K051689 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - DAPTOMYCIN 0.125 - 32 UG/ML | Aug 05, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K051478 | MICROSCAN SYNERGIES PLUS GRAM POSITIVE MIC/COMBO PANELS - RIFAMPIN | Jul 27, 2005 | Substantially Equivalent | Dade Behring, Inc. |
| K051350 | SYNERGIES PLUS GRAM-POSITIVE MIC/COMBO PANELS | Jul 25, 2005 | Substantially Equivalent | Dade Behring, Inc. |
| K051692 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - AMOXICILLIN (STREP) 0.0313 - 32 UG/ML | Jul 14, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K051311 | MICROSCAN SYNERGIES PLUS GRAM POSITIVE MINIMUM INHIBITORY CONCENTRATION/COMBO PANELS - LEVOFLOXACIN | Jul 12, 2005 | Substantially Equivalent | Dade Behring, Inc. |
| K051272 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CLINDAMYCIN (STREP) 0.03125 -4 UG/ML | Jul 11, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K051266 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - LINEZOLID (STREP) 0.25 - 16UG/ML | Jul 05, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K051204 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM CEFEPIME (STREP) 0.0625-4UG/ML | Jun 24, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K051183 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - GATIFLOXACIN (STREP) 0.0625 -8UG/ML | Jun 21, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K051109 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - ERYTHROMYCIN (STREP) 0.0156 - 4UG/ML | Jun 15, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K051138 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFTRIAXONE (STREP) 0.0625 - 4UG/ML | Jun 03, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K050946 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-MEROPENEM (STREP) 0.03125-2 UG/ML | May 27, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K050982 | BD PHONIX AUTOMATED MICROBIOLOGY SYSTEM - CEFOTAXIME STREP (0.0625-4UG/ML) | May 24, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K050976 | VITEK 2 GRAM POSITIVE TRIMETHOPRIM/SULFAMETHOXAZOLE | May 23, 2005 | Substantially Equivalent | bioMerieux, Inc. |
| K050865 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-TRIMETHOPRIM-SULFAMETHOXAZOLE 0.0625/1.2-16/304 UG/ML | May 20, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K050881 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TETRACYCLINE (STREP) 0.0625 - 16 UG/ML | May 12, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K050816 | VITEK 2 GRAM POSITIVE MEROPENEM | May 12, 2005 | Substantially Equivalent | bioMerieux, Inc. |
| K050780 | BD PHOENIXTM AUTOMATED MICROBIOLOGY SYSTEM - PENICILLIN (STREP) 0.156 -32 UG/ML | May 12, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K050747 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM, LEVOFLOXACIN (STREP) 0.25-16 UG/ML | Apr 29, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K050745 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM, VANCOMYCIN (STREP) 0.0625 -32 UG/ML | Apr 29, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K050555 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFAZOLIN (GP) 2-32 UG/ML | Apr 14, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K050400 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEPHALOTHIN (GP) 0.5-64 UG/ML | Mar 22, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K043458 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFOTETAN (GN) 2-64 UG/ML | Mar 15, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K050089 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - AMPICILLIN-SULBACTAM (GP) 2-32 UG/ML | Feb 28, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K050075 | VITEK 2 GRAM POSITIVE DAPTOMYCIN | Feb 28, 2005 | Substantially Equivalent | bioMerieux, Inc. |
| K050076 | VITEK 2 GRAM POSITIVE ERTAPENEM | Feb 18, 2005 | Substantially Equivalent | bioMerieux, Inc. |
| K050002 | VITEK 2 COMPACT | Feb 17, 2005 | Substantially Equivalent | bioMerieux, Inc. |
| K043389 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM -AMPICILLIN-SULBACTAM (GN) 0.5/0.25-32/16UG/ML | Jan 21, 2005 | Substantially Equivalent | Becton, Dickinson & CO |
| K043230 | VITEK GRAM NEGATIVE SUSCEPTIBILITY (GNS) CARD FOR ERTAPENEM | Dec 30, 2004 | Substantially Equivalent | bioMerieux, Inc. |
| K043237 | VITEK GRAM NEGATIVE SUSCEPTIBILITY (GNS) CARD FOR MOXIFLOXACIN | Dec 23, 2004 | Substantially Equivalent | bioMerieux, Inc. |
| K042963 | VITEK GRAM POSITIVE SUSCEPTIBILITY (GPS) CARD FOR ERTAPENEM | Dec 13, 2004 | Substantially Equivalent | bioMerieux, Inc. |
| K042946 | VITEK GRAM POSITIVE SUSCEPTIBILITY (GPS) CARD FOR RIFAMPIN | Dec 07, 2004 | Substantially Equivalent | bioMerieux, Inc. |
| K042932 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-PIPERACILLIN-TAZOBACTAM 0.5/4-128/4 UG/ML | Dec 02, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K041982 | VITEK 2 GRAM NEGATIVE ERTAPENEM | Sep 14, 2004 | Substantially Equivalent | bioMerieux, Inc. |
| K041572 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-PIPERCILLIN (GN) 0.5-128 UG/ML | Aug 12, 2004 | Substantially Equivalent | Becton, Dickinson and Co. |
| K041384 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFTAZIDIME - GRAM NEGATIVE | Aug 03, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K040845 | VITEK 2 ESBL TEST | Jun 08, 2004 | Substantially Equivalent | bioMerieux, Inc. |
| K033458 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CONFIRMATORY ESBL TEST | May 28, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K040716 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-PENICILLIN (GP) 0.0625-32 UG/ML | May 14, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K033907 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TRIMETHOPRIM-SULFAMETHOXAZOLE 0.5/9.5 - 16/304 UG/ML | Apr 09, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K033362 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM- CEFUROXIME GRAM NEGATIVE | Apr 09, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K031601 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH CEPHALOTHIN (0.5-32 UG/ML) | Apr 02, 2004 | Substantially Equivalent | Dade Behring, Inc. |
| K040099 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM | Mar 19, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K040106 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM -- AMPICILLIN -- GRAM POSITIVE | Mar 11, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K032675 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFEPIME (GN) 0.5-65 UG/ML | Mar 01, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K040006 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-LINEZOLID-GRAM POSITIVE | Feb 27, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K033889 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM FOR USE WITH THE ANTIMICROBIAL AGENT CHLORAMPHENICOL 1-32 UG/ML GRAM POSITIVE | Feb 03, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K033784 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - ERYTHROMYCIN 0.0625-8 UG/ML | Feb 03, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K033560 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFTAZIDIME 0.5-64 UG/ML-GRAM-NEGATIVE ID/AST OR AST ONLY PHOENIX PANELS | Jan 14, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K033557 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TICARCILLIN/CLAVULANATE-GRAM NEGATIVE | Jan 14, 2004 | Substantially Equivalent | Becton, Dickinson & CO |
| K033558 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - AZTREONAM 0.5-64 UG/ML-GRAM-NEGATIVE ID/AST OR AST ONLY PHOENIX PANELS | Dec 19, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K033482 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH AMPICILLIN (0.25-128 UG/ML) | Nov 26, 2003 | Substantially Equivalent | Dade Behring, Inc. |
| K033064 | MYCOPLASMA IGG | Nov 26, 2003 | Substantially Equivalent | Trinity Biotech USA |
| K032861 | VITEK 2 GRAM NEGATIVE MOXIFLOXACIN | Nov 12, 2003 | Substantially Equivalent | bioMerieux, Inc. |
| K032788 | VITEK 2 GRAM NEGATIVE GATIFLOXACIN | Nov 04, 2003 | Substantially Equivalent | bioMerieux, Inc. |
| K032766 | VITEK 2 GRAM POSITIVE LINEZOLID | Oct 31, 2003 | Substantially Equivalent | bioMerieux, Inc. |
| K032738 | VITEK 2 GRAM POSITIVE QUINUPRISTIN/DALFOPRISTIN | Oct 31, 2003 | Substantially Equivalent | bioMerieux, Inc. |
| K032711 | VITEK GRAM NEGATIVE GATIFLOXACIN | Oct 31, 2003 | Substantially Equivalent | bioMerieux, Inc. |
| K032655 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFTRIAXONE 0.5-64 UG/ML | Oct 06, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K032275 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-IMIPENEM 1-16 UG/ML GRAM-NEGATIVE ID/AST OR AST ONLY PHOENIX PANELS | Sep 29, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K032299 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM,-AMPICILLIN 0.5.-32 UG/ML | Sep 22, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K032567 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFOXITIN-GRAM NEGATIVE | Sep 17, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K032153 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM CEFOTAXIME 0.5-64 UG/ML | Sep 11, 2003 | Substantially Equivalent | Bd Diagnostic Systems |
| K032399 | VITEK 2 GRAM POSITIVE MOXIFLOXACIN | Sep 10, 2003 | Substantially Equivalent | bioMerieux, Inc. |
| K031984 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-TICARCILLIN-1-128 UG/ML | Aug 27, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K032314 | VITEK 2 GRAM POSITIVE GATIFLOXACIN | Aug 22, 2003 | Substantially Equivalent | bioMerieux, Inc. |
| K032131 | BD AUTOMATED MICROBIOLOGY SYSTEM TETRACYCLINE - GP 0.5-16 UG/ML-GRAM POSITIVE ID/AST OR AST ONLY PHOENIX PANELS | Aug 18, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K031865 | VITEK 2 GRAM POSITIVE MOXIFLOXACIN FOR STREPOCOCCUS PNEUMONIAE | Aug 13, 2003 | Substantially Equivalent | bioMerieux, Inc. |
| K031943 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEPHALOTHIN (GN) 1-64 UG/ML | Aug 06, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K031602 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH NITROFURANTOIN (1-256 UG/ML) | Jul 31, 2003 | Substantially Equivalent | Dade Behring, Inc. |
| K031699 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TRIMETHOPRIM-SULFAMETHOXAZOLE 0.5/9.5-16/304UG/ML | Jul 30, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K031912 | BD PHOENIX AUTOMATED MICRBIOLOGY SYSTEM AMOXICILLIN/CLAVUALANTE 0.5/0.25-32/16 UG/ML | Jul 21, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K031679 | BD PHONENIX AUTOMATED MICROBIOLOGY SYSTEM | Jul 16, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K031589 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-NITROFURANTOIN GRAM POSITIVE | Jul 11, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K031530 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-NITROFURANTOIN-8-512 UG/ML | Jul 10, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K031410 | VITEK 2 GRAM POSITIVE LINEZOLID FOR STREPTOCOCCUS PNEUMONIAE | Jul 10, 2003 | Substantially Equivalent | bioMerieux, Inc. |
| K031429 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-MEROPENEM 0.25-16 UG/ML | Jun 06, 2003 | Substantially Equivalent | Bd Diagnostic Systems |
| K031306 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - MOXIFLOXACIN GRAM POSITIVE | Jun 02, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K030986 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM TRIMETHOPRIM - GN 0.5-16 UG/ML | May 16, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K030677 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-VANCOMYCIN GRAM POSITIVE | Apr 01, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K030579 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-NALIDIXIC ACID - 2-32 UG/ML | Mar 21, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K030091 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - NORFLOXACIN 0.25 - 16 UG/ML | Feb 28, 2003 | Substantially Equivalent | Bd Diagnostic Systems |
| K024153 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TETRACYCLINE - 0.5-16 UG/ML | Feb 10, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K024152 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - RIFAMPIN 0.25-32 UG/ML | Jan 31, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K023568 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM | Jan 24, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K023895 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CIPROFLOXACIN GN | Jan 08, 2003 | Substantially Equivalent | Becton, Dickinson & CO |
| K023634 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-GENTAMICIN GN (0.25-16UG/ML) | Dec 24, 2002 | Substantially Equivalent | Becton, Dickinson & CO |
| K023527 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - NORFLOXACIN - 0.25-16 UG/ML | Dec 23, 2002 | Substantially Equivalent | Becton, Dickinson & CO |
| K023858 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM | Dec 20, 2002 | Substantially Equivalent | Becton, Dickinson & CO |
| K023361 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH GATIFLOXACIN (0.004-16 UG/ML) | Dec 16, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K023541 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH MOXIFLOXACIN (0.004-16UG/ML) | Dec 13, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K023444 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-AMIKACIN-0.5-64 UG/ML | Nov 12, 2002 | Substantially Equivalent | Becton, Dickinson & CO |
| K023301 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM | Nov 12, 2002 | Substantially Equivalent | Becton, Dickinson & CO |
| K023273 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - GENTAMICIN 0.25 - 16 UG/ML | Oct 31, 2002 | Substantially Equivalent | Becton, Dickinson & CO |
| K022045 | VITEK GRAM POSITIVE SUSCEPTIBILITY (GPS) CARD FOR LINEZOLID | Aug 15, 2002 | Substantially Equivalent | bioMerieux, Inc. |
| K022172 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM | Aug 12, 2002 | Substantially Equivalent | Becton, Dickinson & CO |
| K021954 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CLINDAMYCIN 0.125-8.0MCG/ML | Aug 01, 2002 | Substantially Equivalent | Becton, Dickinson & CO |
| K022129 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM MOXIFLOXACIN 0.125-8 UG/ML | Jul 25, 2002 | Substantially Equivalent | Becton, Dickinson & CO |
| K020413 | MICROSCAN SYNERGIES PLUS DRIED GRAM NEGATIVE MIC/COMBO PANELS WITH CEFTAZIDIME (1-16 UG/ML) | Jul 17, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020410 | MICROSCAN RAPID/S PLUS GRAM-NEGATIVE MIC/COMBO PANELS WITH CEPHALOTHIN (2-64 UG/ML) | Jun 11, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020321 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM | May 23, 2002 | Substantially Equivalent | Becton, Dickinson & CO |
| K020398 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH AMPICILLIN (0.25-128 UG/ML) | May 16, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020397 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH PIPERACILLIN (4-256 UG/ML) | Apr 22, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020506 | MICROSCAN SYNERGIES PLUS GRAM-NEGATIVE MIC/COMBO PANELS WITH CEFTRIAXONE (0.5-128 UG/ML) | Apr 17, 2002 | Substantially Equivalent | Dade Microscan, Inc. |
| K020319 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH AMPICILLIN/SULBACTAM (0.5/0.25-64/34 UG/ML) | Apr 17, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020323 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM | Apr 04, 2002 | Substantially Equivalent | Becton, Dickinson & CO |
| K020871 | VITEK 2 ANTIMIRCROBIAL SUSCEPTIBILITY TEST SYSTEM FOR LEVOFLOXACIN | Mar 29, 2002 | Substantially Equivalent | bioMerieux, Inc. |
| K020322 | BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM | Mar 27, 2002 | Substantially Equivalent | Becton, Dickinson & CO |
| K020870 | VITEK 2 ANTIMICROBIAL SUSCEPTIBILITY TEST SYTEM FOR SPARFLOXACIN | Mar 25, 2002 | Substantially Equivalent | bioMerieux, Inc. |
| K020248 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH TRIMETHOPRIM/SULFAMETHOXAZOLE (0.25/4.75-64/1216 UG/ML) | Mar 14, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020142 | MICROSCAN SYNERGIES PLUS | Mar 14, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020511 | MICROSCAN SYNERGIES PLUS | Mar 06, 2002 | Substantially Equivalent | Dade Microscan, Inc. |
| K020328 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH CEFUROXIME (1-64 UG/ML) | Feb 19, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020249 | MICROSCAN PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH MEROPENEM (0.12-32 UG/ML) | Feb 06, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020246 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH IMIPENEM (0.25, 1-32 UG/ML) | Feb 06, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020209 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH AMIKACIN (0.25-128 UG/ML) | Feb 06, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020185 | MICROSCAN RAPID/S PLUS GRAM-NEGATIVE MIC COMBO PANELS WITH GENTAMICIN (0.12-32 UG/ML) | Feb 06, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020182 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH NETILMICIN (0.12-32 UG/ML) | Feb 06, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020173 | MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH TETRACYCLINE (0.12-128 UG/ML) | Feb 06, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K020168 | MICROSCAN SYNERGIS PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH TOBRAMYCIN (0.12-32 UG/ML) | Feb 06, 2002 | Substantially Equivalent | Dade Behring, Inc. |
| K891577 | SCEPTOR DATA MANAGEMENT CENTER SOFTWARE | Jun 02, 1989 | Substantially Equivalent | Bd Becton Dickinson Vacutainer Systems Preanalytic |
| K861958 | REPLIANALYZER | Aug 01, 1986 | Substantially Equivalent | Mct Medical, Inc. |
FEI Numbers
This FDA classification entry is associated with 23 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 23 registration numbers. Click on an entry to view related FDA registrations.